Damaged mitochondria fuel aging inflammation
The chronic low-grade inflammation that comes with old age has long been linked to dementia, heart problems and muscle loss.
Mitochondria are the organelles that produce energy for everything a cell does. As we age, mutations accumulate in mitochondrial DNA (mtDNA) and the quality of these organelles deteriorates. A recent review in Nature Aging maps out in detail how that decline leads to what researchers call inflammaging: the persistent low-level inflammation that characterises ageing.
The link is specific. Damaged mtDNA leaks out of the mitochondria into the cell’s cytoplasm. Once there, it activates a cellular alarm system called the cGAS-STING pathway, a signalling cascade that normally detects viral DNA but also responds to the cell’s own leaked genetic material. The result is a sustained inflammatory signal that pushes cells into aged behaviour and blocks repair processes.
NAD depletion makes things worse
The review also describes how a drop in NAD (nicotinamide adenine dinucleotide, a molecule central to energy metabolism) amplifies the problem. NAD is needed by proteins that monitor mitochondrial quality. When levels fall, that oversight weakens and damaged mitochondria persist longer than they should.
Beyond DNA leakage, the researchers also explain how disruptions in mitophagy (the recycling process by which cells clear damaged mitochondria) allow poor-quality organelles to accumulate.
Targeted strategies under investigation
The review authors discuss several experimental approaches: NAD supplementation, compounds that stimulate mitophagy, and precision tools to selectively disable mutant mtDNA. All of these remain experimental. The review makes no clinical recommendations, but offers a detailed mechanistic framework for future research. From a longevity standpoint, it draws a clear line between energy metabolism and the chronic inflammation that drives ageing.